Evidence map›Paper›PMID 38620281›Full record

ReviewTrends in anaesthesia & critical care2021

Insights into neurological dysfunction of critically ill COVID-19 patients.

Cristian Deana, Lorenzo Verriello, Giada Pauletto, Francesco Corradi, Francesco Forfori, Gianmaria Cammarota, Elena Bignami, Luigi Vetrugno, Tiziana Bove

Open access · greenAbstract readReview
In one paragraph

Review in Trends in anaesthesia & critical care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Different COVID-19 treatments' impact on hospital length of stay.European journal of medical research · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Reply letter to "COVID-19 and Recurrent Status Epilepticus".Acta bio-medica : Atenei Parmensis · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Cristian DeanaAnesthesia and Intensive Care Department, Santa Maria della Misericordia Academic Hospital, ASUFC, Udine, Italy.
Lorenzo VerrielloNeurology Unit, Department of Neurosciences, Santa Maria della Misericordia Academic Hospital, ASUFC, Udine, Italy.
Giada PaulettoNeurology Unit, Department of Neurosciences, Santa Maria della Misericordia Academic Hospital, ASUFC, Udine, Italy.
Francesco CorradiDepartment of Anesthesiology, Ente Ospedaliero Ospedali Galliera, Genova, Italy.
Francesco ForforiDepartment of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
Gianmaria CammarotaDepartment of Anesthesia and Intensive Care, Maggiore della Carità University Hospital, Novara, Italy.
Elena BignamiAnesthesia, Intensive Care and Pain Therapy Service, University-Hospital of Parma, Parma, Italy.
Luigi VetrugnoAnesthesia and Intensive Care Department, Santa Maria della Misericordia Academic Hospital, ASUFC, Udine, Italy.
Tiziana BoveAnesthesia and Intensive Care Department, Santa Maria della Misericordia Academic Hospital, ASUFC, Udine, Italy.
Ospedale Santa Maria della Misericordia di Udine · ITEnte Ospedaliero Ospedali Galliera · ITUniversity of Parma · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel coronavirus spread rapidly around the world infecting millions of people. It was thus declared a pandemic. This new virus damages the lungs. In the most severe cases, it leads to acute respiratory failure that requires intensive care treatment. However, many clinical reports have listed different neurological symptoms, leading to increased interest in the neurological involvement of COVID-19. Various pathophysiological mechanisms have been proposed to explain these neurological aspects. Direct viral invasion of the nervous system, systemic cytokine storm and severe hypoxemia are key factors in the development of symptoms. Critically ill patients present several additional risk factors for nervous system damage. Reasons for these include deep sedation and extended muscular paralysis, bed rest for several days, and the inability to receive proper physical rehabilitation. After ICU treatment, COVID-19 patients generally require an extensive rehabilitation program. However, distancing restrictions mean that in many cases physiotherapists are unable to enter ICUs, delaying the process of rehabilitation. The role of telemedicine should be considered as an adjunctive tool in the rehabilitation of critically ill COVID-19 patients.

Indexed as

Acute neurological involvementAcute respiratory failureCOVID-19Critically ill patientsNeurologyRehabilitation

Identifiers

PMID38620281
PMCPMC7490585
OpenAlexW3084673434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.